Conmed Corp
NYSE:CNMD
Relative Value
The Relative Value of one
CNMD
stock under the Base Case scenario is
90.86
USD.
Compared to the current market price of 37.34 USD,
Conmed Corp
is
Undervalued by 59%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
CNMD Competitors Multiples
Conmed Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Conmed Corp
NYSE:CNMD
|
1.2B USD | 0.9 | 24.9 | 10.9 | 18.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.3B USD | 4.3 | 29.5 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.4B USD | 17 | 60 | 45.5 | 56 | |
| US |
|
Stryker Corp
NYSE:SYK
|
133.5B USD | 5.3 | 41.1 | 21 | 25.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.5B USD | 3.2 | 24.6 | 13.6 | 19.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 5.3 | 36.4 | 21.4 | 28.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.4B EUR | 1.9 | 20.6 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 8.1 | 45.6 | 25.1 | 27.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.8B USD | 10.9 | 44.2 | 31.3 | 34.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46B USD | 2.1 | 26.2 | 10.3 | 17.3 | |
| US |
|
Resmed Inc
NYSE:RMD
|
34B USD | 6.3 | 22.9 | 16.1 | 17.9 |